Vape's Acquisition of BetterChem Bolsters IP Portfolio
ACCESSWIRE - Mon Jul 06, 8:15AM CDT
SEATTLE, WA / ACCESSWIRE / July 6, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, but the big question on the minds of investors is which companies are best positioned to profit.
GWPH: 125.86 (+5.39), DD: 58.25 (+0.35)
Why Cannabis Labs Make for Compelling Investments
ACCESSWIRE - Tue Jun 30, 8:00AM CDT
SEATTLE, WA / ACCESSWIRE / June 30, 2015 / Marijuana lab testing revenue could reach $850 million by 2020, according to a new report by GreenWave Advisors, an independent investment research and advisory firm serving the burgeoning cannabis industry. Driven by state-mandated cannabis testing requirements, investors may want to take a closer look at the lab testing segment of the industry as a potential investment opportunity.
CrowdGather: An Emerging Nexus for Digital Cannabis
ACCESSWIRE - Mon Jun 01, 7:00AM CDT
WHITEFISH, MT / ACCESSWIRE / June 1, 2015 / Paul Graham, a famous venture capitalist and founder of YCombinator, once summarized a good start-up founder in two words - relentlessly resourceful.
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials
PR Newswire - Wed May 27, 7:05AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, has announced a Historic Collaborative Drug Development deal with IGXBio and its GenePro®, a DNA-based immunotherapeutic that recently received FDA IND approval to enter into human trials. The companies intend to develop a joint protocol to demonstrate potential synergistic effects of their respective drug candidates in HIV, as well as potential new drug candidates.
Peak Pharma Reports Sustained Revenue Growth in Q2 2015
ACCESSWIRE - Wed May 20, 8:16AM CDT
WHITEFISH, MT / ACCESSWIRE / May 20, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while pet spending reached nearly $60 billion last year, according to the American Pet Products Association.
HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), IDXX: 64.09 (+1.22), WOOF: 56.57 (+2.81)
OmniCanna (ENDO) Today Launches www.TheHempery.com "Specialized Hemp Based Health and Wellness" Online Store
PR Newswire - Wed May 20, 8:12AM CDT
OmniCanna Health Solutions, Inc. (OTC: ENDO), a U.S. Company specializing in hemp formulation-based health and wellness solutions, is pleased to announce the launch of www.TheHempery.com and the online store is open for business available for product purchases as of today.
Consumers Becoming More Aware of Hemp's Nutritional Benefits as Companies Race to Introduce Healthy, Cannabis Infused Beverages
PR Newswire - Wed May 20, 7:45AM CDT
Hemp-based consumer products for the nutraceutical, pharmaceutical and supplement industries continue to evolve as more and more states nationwide soften on restrictions for Legal & Medical Marijuana industries. Marijuana & Cannabis Based Companies in focus today are: Algae International Group, Inc. (OTC: ALGA), Hemp, Inc. (OTC: HEMP), Easton Pharmaceuticals (OTC: EAPH), DigiPath, Inc. (OTC: DIGP), American Green, Inc. (OTC: ERBB) and Cannabis Science, Inc. (OTC: CBIS).
CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo'
PR Newswire - Tue May 19, 9:42AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Purple Haze Properties CEO Andrew Pitsicalis will be representing individual and joint medicinal products created with CBIS for "Jimi's Cannabis Collection" including genetic strains and products at the Chicago "Marijuana Business Conference and Expo." Cannabis Science and Purple Haze Properties are working together to launch exciting lines of quality cannabis products using scientific genetics and creating an education platform to share information from doctors and patients around the world about the advances of cannabis research.
OmniCanna Health Solutions, Inc. (ENDO) Names Greta Gaines as CEO & President as Company Prepares for US Release of 'The Hempery' Product Line on May 20, 2015
PR Newswire - Mon May 18, 8:18AM CDT
OmniCanna Health Solutions, Inc. (OTC: ENDO) (fka "Endocan Corporation"
Cannabis Chemistry: A Look at Vape Holdings' Scientific Approach
ACCESSWIRE - Tue May 12, 8:58AM CDT
WHITEFISH, MT / ACCESSWIRE / May 12, 2015 / The legal cannabis industry generated about $2.7 billion in revenue in 2014, according to ArcView Market Research. With that figure expected to grow at a double-digit rate over the coming decade, there has been no shortage of companies entering the space. Some companies, like Cannabis Science Inc. (PINKSHEETS: CBIS) and GW Pharmaceuticals (NASDAQ: GWPH) are focused on pharmaceutical opportunities, while others like Agritek Holdings Inc. (OTC: AGTK) are focused on branding and real estate.
GWPH: 125.86 (+5.39), DD: 58.25 (+0.35)
Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the $60 Billion Pet Care Industry
PR Newswire - Thu May 07, 11:58AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce the acquisition of Equi-Pharm LLC, a USA manufacturer and distributor of specialty horse and pet grooming and topical applications. The acquisition incorporates an extensive expansion plan for Equi-Pharm including "Large Animal" such as horses, cattle, sheep and the like and "Small Animal" or "Pets" include cats, dogs, pet snakes and the like for medical and cosmetic products.
Cannabis Science (CBIS) Accepted To Present at ICAR 2015
PR Newswire - Wed Apr 22, 7:27AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce the acceptance of its presentation next month at the 28th International Conference on Antiviral Research (ICAR) in Rome, Italy.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part II
Anthony Cataldo - at Seeking Alpha - Thu Apr 16, 1:14AM CDT
CARA: 13.28 (+0.52)
Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD"
VSI: 36.98 (+0.41), AMZN: 443.51 (+9.12), CARA: 13.28 (+0.52), HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), GWPH: 125.86 (+5.39), GNC: 44.16 (+0.10), WOOF: 56.57 (+2.81)
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom
PR Newswire - Thu Apr 02, 11:51AM CDT
ImmunoClin Corporation (OTC Markets: IMCL), a healthcare company specialized in personalized medicine, announces that its wholly owned subsidiary, ImmunoClin Ltd., received a controlled drug license from the UK government to possess, supply and produce schedule 1 drugs in its UK laboratory.
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
PR Newswire - Tue Mar 31, 7:37AM CDT
Cannabis Science, Inc. (OTCQB: CBIS) today announced it has entered into a one-year agreement with Derwin A. Wallace to provide financial and investor relations services for the Company. Mr. Wallace will focus on developing and expanding the Company's financial communications with the institutional and retail investment communities and initiate coverage from research analysts through a comprehensive financial and investor relations program.
Penny Stocks Buzz for Blue Water, Imageware Systems, Megola, Baltia Air Lines, Cannabis Science, and MEDL Mobile
PR Newswire - Mon Mar 30, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Blue Water (OTCBB: BLUU), Imageware Systems (OTCMKTS: IWSY), Megola (OTCMKTS: MGON), Baltia Air Lines (OTCMKTS: BLTA), Cannabis Science (OTCMKTS: CBIS), and MEDL Mobile (OTCMKTS: MEDL).
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
PR Newswire - Thu Mar 26, 9:09AM CDT
Choosing to present its products to the world at this year's Spannabis Fair, held March 20-22 in Barcelona, Spain, Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with representatives of businesses and organizations interested in providing the products to their customers from across Spain.
Former National Institute Of Health (NIH) Scientist Allen A. Herman, M.B., Ch.B., Ph.D., Joins The Cannabis Science Scientific Advisory Board (SAB)
PR Newswire - Fri Mar 20, 10:01AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that accomplished scholar, epidemiologist, and public health physician Allen A. Herman, M.B., Ch.B., Ph.D. has joined its scientific advisory board.
Cannabis Science (CBIS) Retains Cohen Grassroots Research Firm To Initiate Coverage Beginning With A 115-Page Analytical Report
PR Newswire - Wed Mar 18, 5:02AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Cohen Grassroots Research, Inc. (CGR), Wall Street's leading independent micro-cap and cannabis research firm, has been retained by the Company to initiate intricate analytical coverage of the Company.